← FDA Drug Approvals (Drugs@FDA)
IBUPROFEN AND FAMOTIDINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2021-10-29
Drug application
- FDA Application #
ANDA211278- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- IBUPROFEN AND FAMOTIDINE
- Generic name
- Famotidine
- Active ingredients
- FAMOTIDINE; IBUPROFEN
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- TEVA PHARMS USA
- First approval
- 2021-10-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown